|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: FLEMINGTON PHARMACEUTICAL CORP, 10QSB, 2000-06-14 |
Next: TRANSGENOMIC INC, S-1/A, 2000-06-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> JUL-31-2000
<PERIOD-END> APR-30-2000
<CASH> 1,018
<SECURITIES> 0
<RECEIVABLES> 137
<ALLOWANCES> 15
<INVENTORY> 0
<CURRENT-ASSETS> 1,287
<PP&E> 29
<DEPRECIATION> 0
<TOTAL-ASSETS> 1,386
<CURRENT-LIABILITIES> 148
<BONDS> 0
0
0
<COMMON> 6
<OTHER-SE> 1,232
<TOTAL-LIABILITY-AND-EQUITY> 1,386
<SALES> 242
<TOTAL-REVENUES> 272
<CGS> 0
<TOTAL-COSTS> 1,055
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (783)
<INCOME-TAX> 0
<INCOME-CONTINUING> (783)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (783)
<EPS-BASIC> (.20)
<EPS-DILUTED> (.20)
</TABLE>
|
|